换一批
换一批Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
作者：
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);氨基酸取代(Amino Acid Substitution);贫血, 难治性(Anemia, Refractory);贫血, 铁粒幼细胞性(Anemia, Sideroblastic);疾病恶化(Disease Progression);女(雌)性(Female);随访研究(Follow-Up Studies);基因频率(Gene Frequency);人类(Humans);Janus激酶2(Janus Kinase 2);巨核细胞(Megakaryocytes);突变, 误义(Mutation, Missense);骨髓增生异常综合征(Myelodysplastic Syndromes);骨髓增殖性疾病(Myeloproliferative Disorders);点突变(Point Mutation);原发性骨髓纤维化(Primary Myelofibrosis);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);原癌基因蛋白质类(Proto-Oncogene Proteins);血小板增多(Thrombocytosis);世界卫生组织(World Health Organization)
PMID
16670082
发布时间
2012-11-15
- 浏览28
Haematologica
719-20页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
